Welcome : Guest

ACADIA Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about ACADIA Pharmaceuticals, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 30 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-10077
Price: $1500
Company Type: Public
Pages: 34
Date: November 2016
Market Data Tables: 30

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Biopharmaceuticals......4
Table 1: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......4
Glaucoma Drugs......5
Table 2: Glaucoma Drugs Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonists (AA), Beta Blocker Fixed Combos (BB-FC), Beta Blockers (BB), Carboic Anhydrase Inhibitors (CAI) and Prostaglandins (PGA)......5
Table 3: Glaucoma Disease Market for Prostaglandin Analogs (PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Latanoprost, Lumigan, Travatan and Others......6
Table 4: Glaucoma Disease Market for Non Prostaglandin Analogs (Non-PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blockers (alone), Beta Blockers (combo), Canbone Anymore and Others......7
Table 5: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......8
Parkinson's Disease......9
Table 6: Parkinson's Market by Type Worldwide (2015) - Percentage Breakdown by Volume for Mild, Moderate and Severe......9
Table 7: Population Affected with Parkinson's by Age Group in the US (2015) - Percentage Share Breakdown for 65-69, 70-74, 75-79, 80-84 and 85+......10
Central Nervous System (CNS) Drugs......11
Table 8: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......11
Table 9: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......12
Anti-Psychotics......13
Table 10: Anti-Psychotics Market Worldwide (2015-2020) in US$ '000......13
Table 11: Prescribed Atypical Antipsychotic Market by Type in the US (2015) - Percentage Share Breakdown by Value for 5HT1A Agonist, H1, Antagonist, D2 and 5HT2, D2 and 5HT2A, and Partial D2 Agonist......14
Chronic Pain......15
Table 12: No. of Population with Chronic Pain by Age in the US (2015) - Percentage Share Breakdown by Volume for 18 & over and 18 & Under......15
Table 13: No. of Population with Chronic Pain by Type in the US (2015) - Percentage Breakdown by Volume for Back Pain and Other Pain......16
Table 14: Chronic Pain in Adults by Pain Type in the US (2015) - Percentage Share Breakdown by Volume for Knee Pain, Low Back Pain, Serve Headache or Migraine......17
Table 15: No. of People with Chronic Pain in the US (2015-2020) in Million......18
Spinal Cord Stimulation (SCS) for Chronic Pain......19
Table 16: Spinal Cord Stimulation (SCS) for Chronic Pain by Category in the US (2015) - Percentage Share Breakdown by Volume for Back Pain alone, Leg & Back Pain, Leg Pain alone and Upper Extremity Pain......19
Table 17: Spinal Cord Stimulation (SCS) Population by Category in the US (2015) - Percentage Share Breakdown by Volume for Failed Back Surgery Syndrome, Oral Opioids, and Others......20
Table 18: Spinal Cord Stimulation Systems for Chronic Pain (incl. back pain, leg pain and back/leg pain) Market Worldwide (2015) in US$ Million......21
Biopharmaceuticals......22
Table 19: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......22
Table 20: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......23
Alzheimer's Disease Drugs......24
Table 21: Market Shares of Leading Alzheimer Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......24
Table 22: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......25
Ophthalmology Drugs......26
Table 23: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......26
Table 24: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......27
Central Nervous System (CNS) Medicines......28
Table 25: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......28
Table 26: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......29
Antipsychotics......30
Table 27: Anti-Psychotic Market by Drug Type Worldwide (2015) - Percentage Share Breakdown by Value for Abilify, Abilify Maintena, Invega Sustenna, Latuda, Risperdal Consta, Seroquel XR, and Others......30
Table 28: Market Shares of Leading Prescribed Atypical Antipsychotic Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., and Johnson & Johnson Private Limited......31
Table 29: Market Shares of Leading Prescribed Atypical Antipsychotic Brands in the US (2015) - Percentage Share Breakdown by Value for Abilify, Invega, Latuda, Risperdal, Seroquel, and Others......32
Table 30: New Prescription Market for Atypical Antipsychotic Drugs in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......33